Pediatric high-grade glioma: current molecular landscape and therapeutic approaches
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pediatric high-grade glioma: current molecular landscape and therapeutic approaches
Authors
Keywords
Pediatric glioblastoma, Pediatric astrocytoma, Pediatric brain tumor
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume 134, Issue 3, Pages 541-549
Publisher
Springer Nature
Online
2017-03-29
DOI
10.1007/s11060-017-2393-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IDH1 mutation can be present in diffuse astrocytomas and giant cell glioblastomas of young children under 10 years of age
- (2016) Sean P. Ferris et al. ACTA NEUROPATHOLOGICA
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy
- (2016) Cassie N. Kline et al. NEURO-ONCOLOGY
- Integrated analysis of pediatric glioblastoma reveals a subset of biologically favorable tumors with associated molecular prognostic markers
- (2015) Andrey Korshunov et al. ACTA NEUROPATHOLOGICA
- Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
- (2015) David Castel et al. ACTA NEUROPATHOLOGICA
- Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas
- (2015) Yuchen Jiao et al. Oncotarget
- Complete clinical regression of a BRAF V600E-mutant pediatric glioblastoma multiforme after BRAF inhibitor therapy
- (2014) Giles W Robinson et al. BMC CANCER
- 5-ALA fluorescence-assisted surgery in pediatric brain tumors: Report of three cases and review of the literature
- (2014) Giuseppe M. V. Barbagallo et al. BRITISH JOURNAL OF NEUROSURGERY
- Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas
- (2014) Ian F. Pollack et al. JOURNAL OF CLINICAL ONCOLOGY
- Near-infrared imaging of brain tumors using the Tumor Paint BLZ-100 to achieve near-complete resection of brain tumors
- (2014) Pramod V. Butte et al. Neurosurgical Focus
- Mutations in SETD2 and genes affecting histone H3K36 methylation target hemispheric high-grade gliomas
- (2013) Adam M. Fontebasso et al. ACTA NEUROPATHOLOGICA
- TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
- (2013) P. J. Killela et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hotspot Mutations in H3F3A and IDH1 Define Distinct Epigenetic and Biological Subgroups of Glioblastoma
- (2012) Dominik Sturm et al. CANCER CELL
- Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
- (2012) Jeremy Schwartzentruber et al. NATURE
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
- (2012) Gang Wu et al. NATURE GENETICS
- PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcome
- (2012) S. Mueller et al. NEURO-ONCOLOGY
- Targeted Therapy for BRAFV600E Malignant Astrocytoma
- (2011) T. P. Nicolaides et al. CLINICAL CANCER RESEARCH
- Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology Group
- (2011) K. J. Cohen et al. NEURO-ONCOLOGY
- Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
- (2011) Paul B. Chapman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncogenic BRAF Mutation with CDKN2A Inactivation Is Characteristic of a Subset of Pediatric Malignant Astrocytomas
- (2010) J. D. Schiffman et al. CANCER RESEARCH
- IDH1 mutations are common in malignant gliomas arising in adolescents: a report from the Children’s Oncology Group
- (2010) Ian F. Pollack et al. CHILDS NERVOUS SYSTEM
- Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease
- (2010) Barbara S. Paugh et al. JOURNAL OF CLINICAL ONCOLOGY
- A Pyrosequencing-Based Assay for the Rapid Detection of IDH1 Mutations in Clinical Samples
- (2010) Prashanth Setty et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children’s Oncology Group
- (2010) Ian F. Pollack et al. JOURNAL OF NEURO-ONCOLOGY
- Intensive chemotherapy improves survival in pediatric high-grade glioma after gross total resection: results of the HIT-GBM-C protocol
- (2009) Johannes E.A. Wolff et al. CANCER
- EGFRvIII Deletion Mutations in Pediatric High-Grade Glioma and Response to Targeted Therapy in Pediatric Glioma Cell Lines
- (2009) D. A. Bax et al. CLINICAL CANCER RESEARCH
- Late Effects of Conformal Radiation Therapy for Pediatric Patients With Low-Grade Glioma: Prospective Evaluation of Cognitive, Endocrine, and Hearing Deficits
- (2009) Thomas E. Merchant et al. JOURNAL OF CLINICAL ONCOLOGY
- Myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for childhood central nervous system tumors
- (2008) A Marachelian et al. BONE MARROW TRANSPLANTATION
- Radiation-induced brain tumours after central nervous system irradiation in childhood: a review
- (2008) Benedetta Ludovica Pettorini et al. CHILDS NERVOUS SYSTEM
- Protein Expression of Platelet-Derived Growth Factor Receptor Correlates with Malignant Histology and PTEN with Survival in Childhood Gliomas
- (2008) H. K. Thorarinsdottir et al. CLINICAL CANCER RESEARCH
- Tyrosine kinase expression in pediatric high grade astrocytoma
- (2008) Muh-Lii Liang et al. JOURNAL OF NEURO-ONCOLOGY
- Proton versus photon radiotherapy for common pediatric brain tumors: Comparison of models of dose characteristics and their relationship to cognitive function
- (2008) Thomas E. Merchant et al. PEDIATRIC BLOOD & CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started